Xue‐Jun Guo

1.3k total citations
41 papers, 859 citations indexed

About

Xue‐Jun Guo is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xue‐Jun Guo has authored 41 papers receiving a total of 859 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 8 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xue‐Jun Guo's work include Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Treatments and Mutations (4 papers) and Cancer Genomics and Diagnostics (3 papers). Xue‐Jun Guo is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Treatments and Mutations (4 papers) and Cancer Genomics and Diagnostics (3 papers). Xue‐Jun Guo collaborates with scholars based in China, United States and Germany. Xue‐Jun Guo's co-authors include Zhong‐Yi Dong, Li Liu, Jian Wang, Qin Zeng, Dehua Wu, Hongbo Zhu, Xue Bai, Ze-Qin Guo, Hao Sun and Xin-Ran Tang and has published in prestigious journals such as Cancer Research, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Xue‐Jun Guo

38 papers receiving 848 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xue‐Jun Guo China 13 379 250 237 181 111 41 859
Madan Lal Brahma Bhatt India 20 259 0.7× 154 0.6× 556 2.3× 264 1.5× 95 0.9× 79 1.1k
Ji Hyung Hong South Korea 17 274 0.7× 230 0.9× 209 0.9× 159 0.9× 92 0.8× 59 920
Faisal Azam Saudi Arabia 13 393 1.0× 153 0.6× 176 0.7× 90 0.5× 71 0.6× 43 908
Yueh‐Chun Lee Taiwan 19 188 0.5× 164 0.7× 324 1.4× 204 1.1× 132 1.2× 72 961
Zhu Feng China 3 212 0.6× 222 0.9× 518 2.2× 261 1.4× 105 0.9× 9 1.2k
Faquan Lin China 17 267 0.7× 264 1.1× 161 0.7× 86 0.5× 61 0.5× 102 1.0k
Chengkun Yang China 22 238 0.6× 258 1.0× 591 2.5× 414 2.3× 87 0.8× 73 1.1k
Mojgan Mokhtari Iran 14 216 0.6× 77 0.3× 297 1.3× 172 1.0× 107 1.0× 70 986
Yongchang Zheng China 21 330 0.9× 279 1.1× 470 2.0× 319 1.8× 147 1.3× 78 1.4k
Haval Balata United Kingdom 11 263 0.7× 536 2.1× 374 1.6× 243 1.3× 183 1.6× 37 992

Countries citing papers authored by Xue‐Jun Guo

Since Specialization
Citations

This map shows the geographic impact of Xue‐Jun Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue‐Jun Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue‐Jun Guo more than expected).

Fields of papers citing papers by Xue‐Jun Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xue‐Jun Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue‐Jun Guo. The network helps show where Xue‐Jun Guo may publish in the future.

Co-authorship network of co-authors of Xue‐Jun Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Xue‐Jun Guo. A scholar is included among the top collaborators of Xue‐Jun Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue‐Jun Guo. Xue‐Jun Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Jiayu, Ruojun Wang, Yanming Deng, et al.. (2025). Multimodal AI-based risk stratification for distant metastasis in nasopharyngeal carcinoma. ESMO Open. 10(10). 105809–105809. 1 indexed citations
3.
Li, Defu, Xue‐Jun Guo, Jianguo Zeng, et al.. (2024). T2 Relaxation Time in Extraocular Muscles of Patients with Mild Thyroid-Associated Ophthalmopathy: Comparing T2 Mapping With and Without FatSuppression Using Different Measurement Methods. Current Medical Imaging Formerly Current Medical Imaging Reviews. 20. e15734056299907–e15734056299907. 3 indexed citations
4.
Tong, Man, Xue‐Jun Guo, Songhu Yuan, et al.. (2024). Reactive oxygen species: the last link in the mass extinction killing chain. Science Bulletin. 70(9). 1398–1401. 1 indexed citations
5.
Guo, Xue‐Jun, et al.. (2024). A wide survey of heavy metals-induced in-vitro DNA replication stress characterized by rate-limited replication. Current Research in Toxicology. 6. 100152–100152. 1 indexed citations
8.
Ye, Wenjing, et al.. (2023). Oxygenation index and NT-proBNP as predictors of pulmonary hypertension and ventilation/perfusion mismatch in acute pulmonary embolism. Frontiers in Cardiovascular Medicine. 10. 1090805–1090805. 2 indexed citations
9.
Ma, Si-Cong, Ze-Qin Guo, Yan-Pei Zhang, et al.. (2022). PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer. Cancer Research. 83(4). 568–581. 19 indexed citations
10.
Li, Defu, et al.. (2022). Rare massive hepatic hemangioblastoma: A case report. World Journal of Gastrointestinal Oncology. 14(12). 2415–2421. 1 indexed citations
11.
Guo, Xiaoyan, et al.. (2021). Investigation and Analysis of Iron-Deficiency Anemia Complicated by Splenomegaly. International Journal of General Medicine. Volume 14. 4155–4159. 10 indexed citations
12.
Ma, Si-Cong, Hongbo Zhu, Jian Wang, et al.. (2021). De Novo Mutation in Non-Tyrosine Kinase Domain of ROS1 as a Potential Predictor of Immune Checkpoint Inhibitors in Melanoma. Frontiers in Oncology. 11. 666145–666145. 4 indexed citations
13.
Liu, Li, Xue Bai, Jian Wang, et al.. (2019). Combination of TMB and CNA Stratifies Prognostic and Predictive Responses to Immunotherapy Across Metastatic Cancer. Clinical Cancer Research. 25(24). 7413–7423. 233 indexed citations
14.
Wang, Jian, Hao Sun, Qin Zeng, et al.. (2019). HPV-positive status associated with inflamed immune microenvironment and improved response to anti-PD-1 therapy in head and neck squamous cell carcinoma. Scientific Reports. 9(1). 13404–13404. 117 indexed citations
15.
Xiao, Deqiang, Huoling Luo, Yanfang Zhang, et al.. (2017). In vivo comparison of two navigation systems for abdominal percutaneous needle intervention. Abdominal Radiology. 42(7). 1993–2000. 3 indexed citations
16.
Li, Chengye, et al.. (2016). Curcumin modulates the effect of histone modification on the expression of chemokines by type II alveolar epithelial cells in a rat COPD model. International Journal of COPD. Volume 11. 2765–2773. 31 indexed citations
17.
Huang, Kai, Wenchao Yan, Xue‐Jun Guo, et al.. (2014). Intense high repetition rate Mo Kα x-ray source generated from laser solid interaction for imaging application. Review of Scientific Instruments. 85(11). 113304–113304. 20 indexed citations
18.
Yang, Ling, et al.. (2012). The Effect of Stimuli on Basophil-Mediated Atopic Responses During Asthmatic Lying-In Women and in Newborns. Hybridoma. 31(4). 255–261. 3 indexed citations
19.
Guo, Xue‐Jun. (2011). Design of Spatial Data Mining System Based on Spatial Data Miner. Coal Technology. 1 indexed citations
20.
Zhang, Jinxia, Shoufeng Zhang, Xue‐Jun Guo, & Rongliang Hu. (2008). Construction of recombinant retroviral vector of antimicrobial peptide genes and expression in mammary gland. Zhongguo shouyi xuebao. 28(12). 1433–1437. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026